2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Marvelon: new trials by email Literature Review of Marvelon trials Research Report on Marvelon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin Desogestrel and ethinylestradiol fixed dose combination, Follitropin alfa/lutropin alfa - Fertility | Phase 1 | Completed | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 24 | 2025-11-24 | 2026-03-18 |
| Antagonist/Letrozole in Poor Responders letrozole, oral contraceptive (Marvelone), GnRH agonist (buserelin) - Ovarian Stimulation | Phase 1 / Phase 2 | Completed | Yazd Research & Clinical Center for Infertility | 120 | 2008-06-01 | 2013-12-23 |
Infertility (1)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1) · Yazd Research & Clinical Center for Infertility (1)
Iran (1) · United Kingdom (1)